Piramal Pharma Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '24 Sep 30, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Operating Revenue	87,038	81,712	70,816	65,591	58,291
Other Revenue	-	-	-	1,750	576.37
Revenue	87,038	81,712	70,816	67,341	58,868
Revenue Growth (YoY)	14.51%	15.39%	5.16%	14.39%	-
Cost of Revenue	34,681	32,617	29,713	24,512	20,736
Gross Profit	52,357	49,095	41,103	42,829	38,132
Selling, General & Admin	23,310	22,034	21,046	15,888	14,761
Other Operating Expenses	15,559	15,054	13,736	15,477	9,508
Operating Expenses	46,461	44,493	41,549	37,227	29,301
Operating Income	5,896	4,601	-446.5	5,602	8,831
Interest Expense	-4,332	-4,470	-3,377	-1,888	-1,459
Interest & Investment Income	119.2	119.2	16.4	6.8	37.11
Earnings From Equity Investments	656.5	594.9	543.3	590.3	436.06
Currency Exchange Gain (Loss)	304	304	1,108	168.6	565.57
Other Non Operating Income (Expenses)	694.9	763.4	523.3	-94.7	-50.12
EBT Excluding Unusual Items	3,339	1,913	-1,633	4,385	8,361
Merger & Restructuring Charges	-	-	-69.6	-150.8	-416.77
Gain (Loss) on Sale of Investments	42.7	42.7	15.8	19.5	-
Gain (Loss) on Sale of Assets	-4.6	-4.6	-4.8	-5.4	10.52
Asset Writedown	-	-	-	-	-377.08
Other Unusual Items	-158.4	-158.4	490	601.3	1,183
Pretax Income	3,219	1,793	-1,202	4,850	8,760
Income Tax Expense	2,766	1,615	663.1	1,090	1,052
Net Income	453.3	178.2	-1,865	3,760	7,708
Net Income to Common	453.3	178.2	-1,865	3,760	7,708
Net Income Growth	-	-	-	-51.22%	-
Shares Outstanding (Basic)	1,318	1,281	1,190	1,179	628
Shares Outstanding (Diluted)	1,320	1,284	1,190	1,179	628
Shares Change (YoY)	9.21%	7.85%	0.95%	87.83%	-
EPS (Basic)	0.34	0.14	-1.57	3.19	12.28
EPS (Diluted)	0.34	0.14	-1.57	3.19	12.28
EPS Growth	-	-	-	-74.02%	-
Free Cash Flow	-310.4	2,925	-4,809	-1,231	-42.55
Free Cash Flow Per Share	-0.24	2.28	-4.04	-1.04	-0.07
Dividend Per Share	-	0.110	-	0.980	-
Gross Margin	60.15%	60.08%	58.04%	63.60%	64.78%
Operating Margin	6.77%	5.63%	-0.63%	8.32%	15.00%
Profit Margin	0.52%	0.22%	-2.63%	5.58%	13.09%
Free Cash Flow Margin	-0.36%	3.58%	-6.79%	-1.83%	-0.07%
EBITDA	12,873	11,391	5,764	11,099	12,970
EBITDA Margin	14.79%	13.94%	8.14%	16.48%	22.03%
D&A For EBITDA	6,977	6,790	6,211	5,497	4,139
EBIT	5,896	4,601	-446.5	5,602	8,831
EBIT Margin	6.77%	5.63%	-0.63%	8.32%	15.00%
Effective Tax Rate	85.92%	90.06%	-	22.48%	12.01%
Revenue as Reported	88,724	83,466	73,067	68,349	59,806
Advertising Expenses	-	1,423	1,762	1,513	-

Source: S&P Capital IQ. Standard template. Financial Sources.